Amy H. Huang/X
Dec 9, 2025, 08:02
Amy H. Huang: Our Work on Bone Health in Myeloma Has Been Recognized with ASH Abstract Achievement Award
Amy H. Huang, Internal Medicine Resident Physician at University of Connecticut, posted on X:
“Excited to share our work at ASH! This is a bi-institutional study (UConn and Yale) on bone health in myeloma that has been recognized with ASH Abstract Achievement Award.
- Delays in dental screening is a major contributor to guideline nonadherence of bone-modifying agent (BMA) prescriptions. Opportunity for QI initiatives to streamline the process.
- Only around 56% of BMA prescriptions were fully concordant with the IMWG guidelines.
- The occurrence of skeletal events were also found to be similar between patients who received more than 5 years of BMA versus less than 5 years. This raises the question of whether prolonged use of BMA really confers benefit and further research is needed.
Managing morbidities is as important as treating the malignancy itself. Sometimes this is what patients care about the most.”

Get the latest from Hemostasis Today.
-
May 10, 2026, 00:50Abdulla A. Damluji: Pulsed Field Ablation Delivers a New Standard for Persistent AF
-
May 10, 2026, 00:48Kirti Sharma: Immune Thrombocytopenia Market Set for Strong Growth Through 2036
-
May 10, 2026, 00:41Ram Chaganti: Could Immune Tolerance Be Engineered in Chronic Immune Thrombocytopenia?
-
May 9, 2026, 23:50Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
-
May 9, 2026, 23:37Maia Meier’s Journey: Raising Awareness for Women Living Without a Diagnosis – European Haemophilia Consortium
-
May 9, 2026, 23:13Aakanksha Angra: Building a Community for Advances in ALL
-
May 9, 2026, 22:55Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
-
May 9, 2026, 22:43Simon Ash: Gestational Thrombocytopenia and Maternal Risk at SOAPAM 2026
-
May 9, 2026, 22:18Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery